Hydrophilic acrylic IOL shows high long-term safety profile for eyes with uveitis
A hydrophilic acrylic IOL improved vision and maintained a good long-term safety profile in eyes with uveitis, according to a study.
The retrospective study included 171 eyes of 140 patients with uveitis who underwent phacoemulsification and implantation of a Rayner hydrophilic acrylic IOL. Mean patient age was 51 years. Mean follow-up was 3.8 years.
Uveal bioincompatibility was identified in 31 of 171 eyes. Visually insignificant deposits on the IOL were identified in 17 eyes (9.94%).
Capsule bioincompatability was identified in 107 eyes (62.57%); this occurred in 32 eyes (18.71%) at 3 months and in 42 eyes (24.56%) at 6 months.
Posterior capsule opacification developed in 102 eyes (59.65%) at a mean 15 months after surgery. Thirty-one eyes (18.13%) underwent Nd:YAG laser capsulotomy.
Corrected distance visual acuity was 6/12 or better in 72 of 102 eyes (70.59%) at 6 months, 98 eyes of 160 eyes at 1 year (61.25%) and 64 of 113 eyes (56.63%) at 3 years.
Eighty-five percent of eyes had corrected distance visual acuity of better than logMAR 0.3 or sustained a three-line improvement in vision at 1 year, the authors said.
Disclosure: The authors have no relevant financial disclosures.